May 2020 PMID 32222134

Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction.

Paul W Armstrong, Burkert Pieske, Kevin J Anstrom, Justin Ezekowitz, Adrian F Hernandez, Javed Butler, Carolyn S P Lam, Piotr Ponikowski, Adriaan A Voors, Gang Jia, Steven E McNulty, Mahesh J Patel, Lothar Roessig, Joerg Koglin, Christopher M O'Connor

Mentions

242
Peak: 66 in Mar 2020
across 5 sources since Mar 2020

Extended reach

953,704
potential audience

Total likes

682

Video views

11,465

Mentions per month

Mar 2020 – Sep 2025

Where it's discussed

  • X / Twitter203 posts
  • News26 articles
  • Facebook5 posts
  • YouTube4 videos
  • Blogs4 articles

AI synopsis

What people are saying

Many conversations delve into the findings of the VICTORIA trial, with discussions highlighting the reduced risk of cardiovascular death and hospitalization observed with Vericiguat. Phrases like 'game changer' and inquiries about its clinical applications reflect a strong interest, while some posts question the significance of the 10% risk reduction, indicating a mix of cautious optimism and deeper inquiry.

AgreementModerate agreement

Many discussions reflect a general acceptance of Vericiguat’s benefits, although some express skepticism about its clinical significance.

InterestHigh interest

The topic garners noticeable enthusiasm, showcasing a level of excitement regarding the new treatment.

EngagementModerate engagement

While some posts provide critical insights, others demonstrate a basic understanding of the research without diving deeply into the implications.

ImpactHigh impact

A consensus exists that this publication could significantly influence treatment strategies for heart failure patients.

Abstract in brief

  • Vericiguat, a new medication, was tested in a study involving over 5,000 patients with heart failure and reduced ejection fraction, who had recently been hospitalized or treated with diuretics.
  • The study found that patients taking vericiguat experienced fewer primary outcome events (death from cardiovascular causes or first hospitalization for heart failure) compared to those on placebo, with a hazard ratio of 0.90 indicating a 10% reduced risk.
  • Although vericiguat showed promise, the rates of serious side effects like symptomatic hypotension and syncope were similar to placebo, suggesting it could be a safe option for high-risk heart failure patients.

Top posts

Most liked on X and Bluesky
Doç. Dr. Ferhat Arslan
@Ferhatarslandr · X

Sağı solu bloke edip duracağımıza acaba destek mi versek kalp kasına ? Şu daha mantıklı geliyor. https://t.co/6YajYtStCg

Feb 12, 2024 · 129 likes · 18 shares · 226,418 followers View post →
Jesús Álvarez-García
@j_alvarezgarcia · X

(1)

May 24, 2020 · 76 likes · 33 shares · 2,880 followers View post →
Gregg Fonarow MD
@gcfmd · X

Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction | NEJM https://t.co/umwPqPbOmb

Mar 28, 2020 · 39 likes · 14 shares · 11,823 followers View post →
jaumebosch
@jaumebosch9 · X

An example for debating what degree of risk reduction could be considered clinically significant. Here is a 3.5% absolute risk reduction (from 38.5 to 35%). And if it was NASH? Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction | NEJM https://t.co/TelsezpV6L

May 15, 2020 · 25 likes · 2 shares · 2,834 followers View post →
SABOURETCardiologist
@SABOURETCardio · X

#Vericiguat in Patients with #HFrEF : not available in France despite the #ARR of the combined primary endpoint. #HF https://t.co/bNbsGXYlPr

Apr 21, 2024 · 23 likes · 2 shares · 31,096 followers View post →
Takeru Nabeta
@nebetake · X

ベルイシグアトの効果を示した試験VICTORIA trialはこちらになります。 https://t.co/yVxDTTJlBE

Apr 29, 2021 · 20 likes · 3 shares · 2,181 followers View post →

All mentions

Afnan
@afshomrani · X

RT @PGYpharmacy: Academic activity

Aug 10, 2024 · 2 shares · 153 followers View post →
شَهد
@AlshamraniSA_ · X

RT @PGYpharmacy: Academic activity

Aug 10, 2024 · 2 shares · 808 followers View post →
Pharmacy Residency
@PGYpharmacy · X

Academic activity

Aug 10, 2024 · 6 likes · 2 shares · 368 followers View post →
Dr Niranjan MR @ NephroByte MD DM DNB
@drniranjanmr2 · X

Jul 24, 2024 · 3 likes · 891 followers View post →
Paramvir Chauhan MD
@paramvir_dr · X

RT @SABOURETCardio: #Vericiguat in Patients with #HFrEF : not available in France despite the #ARR of the combined primary endpoint. #HF h…

Apr 21, 2024 · 2 shares · 315 followers View post →
JorgeEdoChava75
@QicenoJorge · X

RT @SABOURETCardio: #Vericiguat in Patients with #HFrEF : not available in France despite the #ARR of the combined primary endpoint. #HF h…

Apr 21, 2024 · 2 shares · 997 followers View post →
SABOURETCardiologist
@SABOURETCardio · X

#Vericiguat in Patients with #HFrEF : not available in France despite the #ARR of the combined primary endpoint. #HF https://t.co/bNbsGXYlPr

Apr 21, 2024 · 23 likes · 2 shares · 31,096 followers View post →
Flame
@Flame_laluna · X

RT @Ferhatarslandr: Sağı solu bloke edip duracağımıza acaba destek mi versek kalp kasına ? Şu daha mantıklı geliyor. https://t.co/6YajYtSt…

Feb 14, 2024 · 18 shares · 861 followers View post →
herseyyyboss
@herseyyyboss · X

RT @Ferhatarslandr: Sağı solu bloke edip duracağımıza acaba destek mi versek kalp kasına ? Şu daha mantıklı geliyor. https://t.co/6YajYtSt…

Feb 13, 2024 · 18 shares · 774 followers View post →
Birsen
@BTUR3 · X

RT @Ferhatarslandr: Sağı solu bloke edip duracağımıza acaba destek mi versek kalp kasına ? Şu daha mantıklı geliyor. https://t.co/6YajYtSt…

Feb 13, 2024 · 18 shares · 337 followers View post →
İlhan Doğan
@ilhandogn06 · X

RT @Ferhatarslandr: Sağı solu bloke edip duracağımıza acaba destek mi versek kalp kasına ? Şu daha mantıklı geliyor. https://t.co/6YajYtSt…

Feb 13, 2024 · 18 shares · 621 followers View post →
M. Yavuz KARAHAN
@MYavuzKARAHAN · X

RT @Ferhatarslandr: Sağı solu bloke edip duracağımıza acaba destek mi versek kalp kasına ? Şu daha mantıklı geliyor. https://t.co/6YajYtSt…

Feb 13, 2024 · 18 shares · 2,904 followers View post →
Mehmet Sait
@msbalci1_sait · X

RT @Ferhatarslandr: Sağı solu bloke edip duracağımıza acaba destek mi versek kalp kasına ? Şu daha mantıklı geliyor. https://t.co/6YajYtSt…

Feb 12, 2024 · 18 shares · 2,804 followers View post →
#DevletiminYanindayim
@basderem · X

RT @Ferhatarslandr: Sağı solu bloke edip duracağımıza acaba destek mi versek kalp kasına ? Şu daha mantıklı geliyor. https://t.co/6YajYtSt…

Feb 12, 2024 · 18 shares · 1,423 followers View post →
Şehrazat-
@istiklalim19 · X

RT @Ferhatarslandr: Sağı solu bloke edip duracağımıza acaba destek mi versek kalp kasına ? Şu daha mantıklı geliyor. https://t.co/6YajYtSt…

Feb 12, 2024 · 18 shares · 12,559 followers View post →
Gülçin
@Glin99538522 · X

RT @Ferhatarslandr: Sağı solu bloke edip duracağımıza acaba destek mi versek kalp kasına ? Şu daha mantıklı geliyor. https://t.co/6YajYtSt…

Feb 12, 2024 · 18 shares · 168 followers View post →
Canan
@tastancanan2 · X

RT @Ferhatarslandr: Sağı solu bloke edip duracağımıza acaba destek mi versek kalp kasına ? Şu daha mantıklı geliyor. https://t.co/6YajYtSt…

Feb 12, 2024 · 18 shares · 75 followers View post →
fThKdG
@kdgfth · X

RT @Ferhatarslandr: Sağı solu bloke edip duracağımıza acaba destek mi versek kalp kasına ? Şu daha mantıklı geliyor. https://t.co/6YajYtSt…

Feb 12, 2024 · 18 shares · 118 followers View post →
N.Nadir
@narinos · X

RT @Ferhatarslandr: Sağı solu bloke edip duracağımıza acaba destek mi versek kalp kasına ? Şu daha mantıklı geliyor. https://t.co/6YajYtSt…

Feb 12, 2024 · 18 shares · 1,358 followers View post →
eyüp eryılmaz
@EryilmazEyp · X

RT @Ferhatarslandr: Sağı solu bloke edip duracağımıza acaba destek mi versek kalp kasına ? Şu daha mantıklı geliyor. https://t.co/6YajYtSt…

Feb 12, 2024 · 18 shares · 2,716 followers View post →
Lokman_34
@LokmanErtural · X

RT @Ferhatarslandr: Sağı solu bloke edip duracağımıza acaba destek mi versek kalp kasına ? Şu daha mantıklı geliyor. https://t.co/6YajYtSt…

Feb 12, 2024 · 18 shares · 127 followers View post →
Doç. Dr. Ferhat Arslan
@Ferhatarslandr · X

Sağı solu bloke edip duracağımıza acaba destek mi versek kalp kasına ? Şu daha mantıklı geliyor. https://t.co/6YajYtStCg

Feb 12, 2024 · 129 likes · 18 shares · 226,418 followers View post →
Umut Kocabaş
@UmutKocabasMD · X

RT @drhungo:

Jan 30, 2024 · 3 shares · 1,457 followers View post →
Natsir Ramadhan
@natsiradhan · X

RT @drhungo:

Jan 30, 2024 · 3 shares · 560 followers View post →
Chidambara .ML.
@chidambara09 · X

RT @drhungo:

Jan 29, 2024 · 3 shares · 11,715 followers View post →
Dr Rob
@drhungo · X

Jan 29, 2024 · 1 like · 3 shares · 3,184 followers View post →
Miquel Mas
@DrMqAgMas · X

Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction https://t.co/1LjftVDAcV

Nov 30, 2023 · 2,464 followers View post →
Manu
@manuelpm45 · X

RT @secardiologia: Vericiguat es una nueva molécula para el tratamiento de IC crónica con FEVI<45%. Indicada en pacientes con alto riesgo d…

Mar 7, 2023 · 3 shares · 107 followers View post →
Manu Morales Sánchez
@Manugrillo2 · X

RT @secardiologia: Vericiguat es una nueva molécula para el tratamiento de IC crónica con FEVI<45%. Indicada en pacientes con alto riesgo d…

Mar 7, 2023 · 3 shares · 2,140 followers View post →
Dani Salas
@pollitodeanaga · X

RT @secardiologia: Vericiguat es una nueva molécula para el tratamiento de IC crónica con FEVI<45%. Indicada en pacientes con alto riesgo d…

Mar 6, 2023 · 3 shares · 412 followers View post →
Soc Esp Cardiología
@secardiologia · X

Vericiguat es una nueva molécula para el tratamiento de IC crónica con FEVI<45%. Indicada en pacientes con alto riesgo de descompensación, ha demostrado reducción de muerte cardiovascular y rehospitalizaciones #ClavesIC #eCardio23 https://t.co/behsq4o8kL https://t.co/61TpBNLTuw

Mar 6, 2023 · 5 likes · 3 shares · 59,782 followers View post →
شهد
@Shahad_Albakri · X

@SaraMuhaisni @Banitoto Phase 3 study ( VICTORIA trial) was published in 2020 Real world data is needed! https://t.co/Z6QWmFx1d5

Dec 15, 2022 · 2 likes · 1,382 followers View post →
CardioEd Bot
@CardioBot · X

RT @AAlMohammad87: Interesting that the #TA731 intended by @NICEComms to look into the role of #Vericiguat in the treatment of chronic #HF…

Nov 6, 2022 · 2 shares · 1,205 followers View post →
Dr Rani Khatib FESC
@DrRaniKhatib · X

RT @AAlMohammad87: Interesting that the #TA731 intended by @NICEComms to look into the role of #Vericiguat in the treatment of chronic #HF…

Nov 6, 2022 · 2 shares · 5,423 followers View post →
Abdallah Al-Mohammad
@AAlMohammad87 · X

Interesting that the #TA731 intended by @NICEComms to look into the role of #Vericiguat in the treatment of chronic #HF was terminated pending further submissions. @BSHeartFailure @escardio @TheresaMcDonag3 @MarcoMetra #CardioTwitter #CardioEd @NEJM DOI: 10.1056/NEJMoa1915928

Nov 6, 2022 · 2 likes · 2 shares · 926 followers View post →
にいやん
@niiyan51 · X

Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction https://t.co/XD3pk8eXoo

Oct 28, 2022 · 1 like · 1,074 followers View post →
Takuya Kishi @ねこ好き循環器内科医
@tkishi_cardiol · X

RT @tororo__ph: https://t.co/hLaFljwMnR https://t.co/XM0wOuIsME

Oct 23, 2022 · 1 share · 14,690 followers View post →
Tororo_ph@EP Univ. oshademic
@tororo__ph · X

https://t.co/hLaFljwMnR https://t.co/XM0wOuIsME

Oct 22, 2022 · 1 like · 1 share · 6,800 followers View post →
(仮称)hanzou1121
@hanzou1121 · X

ベリシグアトって心血管死+心不全入院をNNT 33程度で減らすけど死亡・心不全入院をそれぞれわけると有意差つかない、、、くらいの立ち位置の薬なのね。。 https://t.co/zjTOltDLGX

Sep 19, 2022 · 736 followers View post →
David Suasnabar
@SuasnabarDavid · X

RT @cardiomet_CE: 43) Consider the #VICTORIA study: Vericiguat significantly ⬇️ annualized absolute rate of time to #HHF or #CVdeath by 4.2…

Jul 5, 2022 · 3 shares · 57 followers View post →
Sergio Velasquez
@servelros · X

RT @cardiomet_CE: 45b) #vericiguat can be safely combined with other therapies to treat #HF and comorbidities

Jun 22, 2022 · 3 shares · 529 followers View post →
Linda
@wordfinga · X

RT @cardiomet_CE: 45b) #vericiguat can be safely combined with other therapies to treat #HF and comorbidities

Jun 19, 2022 · 3 shares · 4,595 followers View post →
Linda
@wordfinga · X

RT @cardiomet_CE: 43) Consider the #VICTORIA study: Vericiguat significantly ⬇️ annualized absolute rate of time to #HHF or #CVdeath by 4.2…

Jun 19, 2022 · 3 shares · 4,595 followers View post →
Alfonso Valle
@ValleAlfonso · X

RT @cardiomet_CE: 45b) #vericiguat can be safely combined with other therapies to treat #HF and comorbidities

Jun 16, 2022 · 3 shares · 21,712 followers View post →
Alfonso Valle
@ValleAlfonso · X

RT @cardiomet_CE: 43) Consider the #VICTORIA study: Vericiguat significantly ⬇️ annualized absolute rate of time to #HHF or #CVdeath by 4.2…

Jun 16, 2022 · 3 shares · 21,712 followers View post →
cardio-met
@cardiomet_CE · X

45b) #vericiguat can be safely combined with other therapies to treat #HF and comorbidities

Jun 16, 2022 · 9 likes · 3 shares · 4,156 followers View post →
cardio-met
@cardiomet_CE · X

43) Consider the #VICTORIA study: Vericiguat significantly ⬇️ annualized absolute rate of time to #HHF or #CVdeath by 4.2 events/100 patient-year #Vericiguat changes the disease trajectory by reducing recurrent HF #hospitalization

Jun 16, 2022 · 6 likes · 3 shares · 4,156 followers View post →
Mohammed Al Kanan,PharmD,BCPS.
@iK2NAN · X

للاستزاده عن هذا الدواء ، مرفق لكم دراسة محكمة RCTs

Apr 9, 2022 · 5 likes · 5,305 followers View post →
Dr V K Shukla
@VinodShukla1991 · X

RT @sarahhudsonuk: New drugs on the horizon for #HF: @lamcardio talked about the novel oral soluble guanylate cyclase stimulator vericiguat…

Feb 21, 2022 · 2 shares · 93 followers View post →
鯵ゼミ_Journal Club
@AJSR_since2005 · X

#079 Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction N Engl J Med 2020;382:1883-93. VICTORIA試験 ベルイシグアトは、プラセボと比較してHFrEF患者の心血管死と心不全入院の複合エンドポイントを改善させる

Jan 29, 2022 · 6 followers View post →
Samiah Abdullah
@samiah25 · X

Vericiguat: @nejm https://t.co/fTM4dWEJjs https://t.co/Jrmv2qDXjt

Dec 20, 2021 · 1 like · 666 followers View post →
Matías Montero
@Matias_MM_1996 · X

Vericiguat en la reunión de hoy en @Sochicaroficial, exposición de @MirtaDiez4 y moderación de @douglasgreig Se expuso el estudio VICTORIA DOI: 10.1056/NEJMoa1915928 https://t.co/yOs1nk364y

Oct 19, 2021 · 2 likes · 103 followers View post →
Nelson Alvarez
@nelson_alv · X

Vericiguat en pacientes con insuficiencia cardíaca y fracción de eyección reducida https://t.co/hhgmN8EMSJ Entre los Pac con IC de alto riesgo, la incidencia de muerte por causas cardiovasculares u hospitalización por IC fue menor entre los que recibieron Vericiguat VS placebo.

Oct 19, 2021 · 1,035 followers View post →
Serv. Farmacia CHUAC
@FarmaCHUAC · X

Os dejamos aquí el

Sep 21, 2021 · 1 like · 2,253 followers View post →
Lamin F Jarju
@lfjarju · X

VICTORIA Trial https://t.co/RoezG00YZP

Jul 24, 2021 · 31 followers View post →
Cardio-Targets
@CardioTargets · X

Vericiguat in patients with heart failure and reduced ejection fraction https://t.co/ki3exROvZs

Jun 26, 2021 · 153 followers View post →
Estefania Oliveros MD
@EstefaniaOS · X

RT @anudodejamd: What about Grp II PAH? ♦️Do: Rx #GDMT for #HFrEF & #HFPEF ♦️Don't: Rx with pulm vasodilators in pt w/ ⬆️ PCWP ♦️ conside…

May 16, 2021 · 1 share · 3,069 followers View post →
Anu Dodeja, MD, FACC
@anudodejamd · X

What about Grp II PAH? ♦️Do: Rx #GDMT for #HFrEF & #HFPEF ♦️Don't: Rx with pulm vasodilators in pt w/ ⬆️ PCWP ♦️ consider vericiguat in selected pt w/ HFrEF https://t.co/KrakC92EV4 https://t.co/cOhHVC9ovM

May 15, 2021 · 3 likes · 1 share · 1,326 followers View post →
TSK
@TSK010 · X

RT @nebetake: ベルイシグアトの効果を示した試験VICTORIA trialはこちらになります。 https://t.co/yVxDTTJlBE

Apr 30, 2021 · 3 shares · 683 followers View post →
®️
@cho_roto · X

RT @nebetake: ベルイシグアトの効果を示した試験VICTORIA trialはこちらになります。 https://t.co/yVxDTTJlBE

Apr 30, 2021 · 3 shares · 91 followers View post →
ときヲ
@toki_wo_koe · X

いま、ゼンゼンさんに並びなび、多分あと3ロットぐらいの列。 承認となったベルイシグアトを読んでおこう。 (傍で処方が出るのを見るのはずっと先かな

Apr 29, 2021 · 1 like · 2,582 followers View post →
Takeru Nabeta
@nebetake · X

ベルイシグアトの効果を示した試験VICTORIA trialはこちらになります。 https://t.co/yVxDTTJlBE

Apr 29, 2021 · 20 likes · 3 shares · 2,181 followers View post →
Yasser UMKCRCT
@ymhs92 · X

VICTORIA: The use of vericiguat, oral soluble guanylate cyclase stimulator in patients with heart failure was associated with reduced CV death and hospitalizations for HF #UMKCRCT https://t.co/VphG7qt7LY

Apr 19, 2021 · 10 followers View post →
青島周一@【書籍】「生成AIと学ぶ医学論文の読み方・考え方」発売中!
@syuichiao89 · X

Vericiguatもまた微妙な薬よね。 death from cardiovascular causes or first hospitalization for heart failure.▶ https://t.co/qQg8EjTuTJ change in the KCCQ PLS▶ https://t.co/mlRM9PcwZC

Mar 27, 2021 · 8,605 followers View post →
Metabolic Health Digest
@methealthdigest · X

Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction Read more - https://t.co/3RmUXb1x0i #metabolichealthdigest #hypertension #heartfailure #highbloodpressure #bloodpressure #bloodpressureproblems https://t.co/pA8Z256odn

Mar 19, 2021 · 10 followers View post →
Juan Senior
@jsenior64 · X

¿Será que no son comparables por aquello del tratamiento actual? ¿Pero si son tan diferentes el tratamiento adjunto? https://t.co/C1oq5fBhNV

Jan 13, 2021 · 11,061 followers View post →
KristopherMaday PA-C
@PA_Maday · X

VICTORIA Trial Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction https://t.co/y1Gp8opnKy https://t.co/NvUTzYM0kU

Jan 10, 2021 · 1 like · 2,458 followers View post →
Manu Morales Sánchez
@Manugrillo2 · X

RT @JuliaSellerm:

Dec 29, 2020 · 3 shares · 2,140 followers View post →
Anna Sangil
@anna_multitask · X

RT @JuliaSellerm:

Dec 27, 2020 · 3 shares · 103 followers View post →
Dani Salas
@pollitodeanaga · X

RT @JuliaSellerm:

Dec 27, 2020 · 3 shares · 412 followers View post →
Julia Seller
@JuliaSellerm · X

Dec 27, 2020 · 11 likes · 3 shares · 6,014 followers View post →
名前
@akkiii0830 · X

Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction https://t.co/VVJFM4haJF

Dec 16, 2020 · 247 followers View post →
☫кептагоп™Я☫
@kentaron1971 · X

@geraniumlovefo1 これです! https://t.co/OxoBky0Wmz

Dec 8, 2020 · 1 like · 12,427 followers View post →
NCH Internal Medicine Residency
@nch_im · X

Cerebral discussion during journal club today with Dr. Julio Nieto PGY3 on review of “Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction”. Well done Doc! https://t.co/pjuemCRHYI

Nov 11, 2020 · 1 like · 1,376 followers View post →
UC San Diego Cardiology Fellows
@UCSDCardFellows · X

https://t.co/8wx5ETAs9W

Oct 23, 2020 · 1,862 followers View post →
David Téllez
@cdavidta · X

Estimulador de la guanilato ciclasa soluble en pacientes con falla cardiaca y fracción de eyección reducida ¿Realmente mejora la mortalidad por causas cardiovasculares? @JORARTU https://t.co/32D1xFok1N

Sep 22, 2020 · 1 like · 26 followers View post →
Juan Senior
@jsenior64 · X

https://t.co/C1oq5fBhNV

Sep 4, 2020 · 11,061 followers View post →
BSH Nurse Forum
@BSHNurseForum · X

RT @sarahhudsonuk: New drugs on the horizon for #HF: @lamcardio talked about the novel oral soluble guanylate cyclase stimulator vericiguat…

Aug 31, 2020 · 2 shares · 3,157 followers View post →
Sarah Hudson
@sarahhudsonuk · X

New drugs on the horizon for #HF: @lamcardio talked about the novel oral soluble guanylate cyclase stimulator vericiguat and the VICTORIA trial - great potential, with ⬇️CV death/HF hospitalisations with an annual NNT of 24. https://t.co/ExInUzpi7z #ESCCongress #HF https://t.co/OUOVx4kqCc

Aug 31, 2020 · 4 likes · 2 shares · 8,075 followers View post →
ACMX Revista
@ACMrevista · X

RT @smexcardiologia: Aprende más al respecto en la siguiente liga: https://t.co/n3lBT7pFyY #SocMexCardio @ACMrevista @cardiodata @ANCAM_M…

Jul 2, 2020 · 2 shares · 2,885 followers View post →
Rodrigo Gopar
@rodrigogopar · X

RT @smexcardiologia: Aprende más al respecto en la siguiente liga: https://t.co/n3lBT7pFyY #SocMexCardio @ACMrevista @cardiodata @ANCAM_M…

Jul 1, 2020 · 2 shares · 1,248 followers View post →
Sociedad Mexicana de Cardiología
@smexcardiologia · X

Aprende más al respecto en la siguiente liga: https://t.co/n3lBT7pFyY #SocMexCardio @ACMrevista @cardiodata @ANCAM_MEXICO @rodrigogopar @mitrehit @LuisBaeza15 @GreciaRaymundo @drdargaray @aleglezl @daniieelg @MHMichel

Jul 1, 2020 · 5 likes · 2 shares · 15,696 followers View post →
Josh Knowles
@joshuawknowles · X

RT @ChadSWeldy: Got to give Journal Club for @StanCVFellows with faculty discussants including @HeartBobH @EldrinL @Ron_Witteles @joshuawkn…

Jun 17, 2020 · 1 share · 2,402 followers View post →
Chad Weldy, MD, PhD
@ChadSWeldy · X

Got to give Journal Club for @StanCVFellows with faculty discussants including @HeartBobH @EldrinL @Ron_Witteles @joshuawknowles @euanashley and others and I dared to talk about oxidative stress and nitric oxide! Wonderful discussion about VICTORIA https://t.co/c3onW8lNIo

Jun 17, 2020 · 18 likes · 1 share · 1,262 followers View post →
Professor M Z Khalil
@mzkhalil · X

In patients with HFrEF: Add-on #vericiguat Death from cardiovascular causes occurred in 414 patients (16.4%) in the vericiguat group and in 441 patients (17.5%) in the placebo group (hazard ratio, 0.93). | NEJM https://t.co/Zqao4bMOYe https://t.co/hYKxBaQ0ru

Jun 16, 2020 · 2,856 followers View post →
コユキ
@koyukilightsnow · X

RT @ken_korai: NEJMに出てましたけど、日本ではARNIもままならないまま世界で治療が進んでいきますね、、、 https://t.co/MU1pMj18pD リオシグアトと使い勝手は似たようなものなんですかねぇ??

Jun 8, 2020 · 2 shares · 223 followers View post →
高麗謙吾@心臓
@ken_korai · X

NEJMに出てましたけど、日本ではARNIもままならないまま世界で治療が進んでいきますね、、、 https://t.co/MU1pMj18pD リオシグアトと使い勝手は似たようなものなんですかねぇ?? https://t.co/2mTrUCc4bG

Jun 8, 2020 · 3 likes · 2 shares · 11,148 followers View post →
WeeklyReviewer
@ReviewingNews · X

Vericiguat In Patients With Heart Failure And Reduced Ejection Fraction #Cardiovasculardisease #Health #HeartFailure #Medicine #Research #study #Vericiguat https://t.co/vafr7hieVK

Jun 1, 2020 · 967 followers View post →
Brienne Miner
@SleepinBeautyMD · X

RT @geri_doc: Yet another NEJM CHF study with composite outcome of death or hospitalization. It is 2020. Why is this considered a NEJM w…

May 26, 2020 · 15 shares · 532 followers View post →
Mr. Dexametasona
@DrDexametasona · X

RT @j_alvarezgarcia: (1)

May 24, 2020 · 33 shares · 574 followers View post →
Maruan C Chabbar
@MaruanCarlos · X

RT @j_alvarezgarcia: (1)

May 24, 2020 · 33 shares · 1,489 followers View post →
NotiSalud.com.ve
@NotiSalud · X

RT @j_alvarezgarcia: (1)

May 24, 2020 · 33 shares · 43,013 followers View post →
Regina Dalmau
@reginadalmau · X

RT @j_alvarezgarcia: (1)

May 24, 2020 · 33 shares · 4,457 followers View post →
Anna Sangil
@anna_multitask · X

RT @j_alvarezgarcia: (1)

May 24, 2020 · 33 shares · 103 followers View post →
Dani Salas
@pollitodeanaga · X

RT @j_alvarezgarcia: (1)

May 24, 2020 · 33 shares · 412 followers View post →
Manuel Méndez
@mendez_bailon · X

RT @j_alvarezgarcia: (1)

May 24, 2020 · 33 shares · 7,783 followers View post →
Ricardo B.
@ragb1522 · X

RT @j_alvarezgarcia: (1)

May 24, 2020 · 33 shares · 50 followers View post →
Nicolas Renna, MD PhD ISHF FESC
@nicolasrennamd · X

RT @j_alvarezgarcia: (1)

May 24, 2020 · 33 shares · 935 followers View post →
Dr. Angelo Martinez Urb.
@DrAmartinezur93 · X

RT @j_alvarezgarcia: (1)

May 24, 2020 · 33 shares · 516 followers View post →
Dra Sauce Pérez
@AnaSaucePer · X

RT @j_alvarezgarcia: (1)

May 24, 2020 · 33 shares · 450 followers View post →
Societat Catalana de Cardiologia
@catcardio · X

RT @j_alvarezgarcia: (1)

May 24, 2020 · 33 shares · 4,107 followers View post →
Mercedes Rivas-Lasarte
@m_rivaslasarte · X

RT @j_alvarezgarcia: (1)

May 24, 2020 · 33 shares · 905 followers View post →
Joanne Lynn
@DrJoanneLynn · X

RT @geri_doc: Yet another NEJM CHF study with composite outcome of death or hospitalization. It is 2020. Why is this considered a NEJM w…

May 24, 2020 · 15 shares · 625 followers View post →
Pedro Cepas
@pedro_cepas · X

RT @j_alvarezgarcia: (1)

May 24, 2020 · 33 shares · 2,038 followers View post →
Alejandro I. Pérez Cabeza
@alejandroipc2 · X

RT @j_alvarezgarcia: (1)

May 24, 2020 · 33 shares · 1,164 followers View post →
Diego Araiza MD
@drdargaray · X

RT @j_alvarezgarcia: (1)

May 24, 2020 · 33 shares · 8,417 followers View post →
Gonzalo Perez
@gonzaeperez · X

RT @j_alvarezgarcia: (1)

May 24, 2020 · 33 shares · 17,204 followers View post →
Jesús Álvarez-García
@j_alvarezgarcia · X

(1)

May 24, 2020 · 76 likes · 33 shares · 2,880 followers View post →
renalRCTs
@renalRCTs · X

Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction. https://t.co/xwr845ifBG https://t.co/7zPfZMnQLE

May 23, 2020 · 39 followers View post →
Krishan Maggon
@kkmaggon · X

Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction | NEJM https://t.co/T2AUmMBce5 https://t.co/vbOy0d3Los

May 23, 2020 · 1,001 followers View post →
Adams CardioMD
@AdamsCardioMD · X

Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction | NEJM https://t.co/Csd7SL0gXr

May 21, 2020 · 607 followers View post →
Adams CardioMD
@AdamsCardioMD · X

Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction | NEJM https://t.co/MZyPeC1jWP

May 21, 2020 · 607 followers View post →
Ankur B
@DrAnkurB · X

RT @geri_doc: Yet another NEJM CHF study with composite outcome of death or hospitalization. It is 2020. Why is this considered a NEJM w…

May 20, 2020 · 15 shares · 3,630 followers View post →
Aurema Otero
@Aurema_Otero · X

https://t.co/FQ3uh1CgGV Me gustan mucho estos vídeos informativos sobre estudios, pero nunca pueden reemplazar la revisión crítica de un artículo. https://t.co/PNyf9ApM43

May 19, 2020 · 312 followers View post →
Meredith Gilliam
@MAGmdmph · X

RT @geri_doc: Yet another NEJM CHF study with composite outcome of death or hospitalization. It is 2020. Why is this considered a NEJM w…

May 18, 2020 · 15 shares · 745 followers View post →
Not Hike
@Not_Hike · X

RT @geri_doc: Yet another NEJM CHF study with composite outcome of death or hospitalization. It is 2020. Why is this considered a NEJM w…

May 18, 2020 · 15 shares · 132 followers View post →
Gabi LS
@erudainthur · X

RT @geri_doc: Yet another NEJM CHF study with composite outcome of death or hospitalization. It is 2020. Why is this considered a NEJM w…

May 18, 2020 · 15 shares · 50 followers View post →
Canadian Geriatrics
@CanGeriSoc · X

RT @geri_doc: Yet another NEJM CHF study with composite outcome of death or hospitalization. It is 2020. Why is this considered a NEJM w…

May 18, 2020 · 15 shares · 6,031 followers View post →
Francesc Formiga
@FormigaFrancesc · X

RT @geri_doc: Yet another NEJM CHF study with composite outcome of death or hospitalization. It is 2020. Why is this considered a NEJM w…

May 18, 2020 · 15 shares · 1,947 followers View post →
Marlon Aliberti
@marlon_aliberti · X

RT @geri_doc: Yet another NEJM CHF study with composite outcome of death or hospitalization. It is 2020. Why is this considered a NEJM w…

May 18, 2020 · 15 shares · 760 followers View post →
Nicole L. Stout DPT, FAPTA
@NicoleStoutPT · X

RT @geri_doc: Yet another NEJM CHF study with composite outcome of death or hospitalization. It is 2020. Why is this considered a NEJM w…

May 18, 2020 · 15 shares · 8,805 followers View post →
Marie Bakitas
@MBakitas · X

RT @geri_doc: Yet another NEJM CHF study with composite outcome of death or hospitalization. It is 2020. Why is this considered a NEJM w…

May 18, 2020 · 15 shares · 959 followers View post →
Siri Rostoft
@SRostoft · X

RT @geri_doc: Yet another NEJM CHF study with composite outcome of death or hospitalization. It is 2020. Why is this considered a NEJM w…

May 18, 2020 · 15 shares · 122 followers View post →
Geriatrician Nishi
@GeriMedMD · X

RT @geri_doc: Yet another NEJM CHF study with composite outcome of death or hospitalization. It is 2020. Why is this considered a NEJM w…

May 18, 2020 · 15 shares · 1,674 followers View post →
Jorge Alegria MD
@Jorge_AlegriaMD · X

Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction Just read the VICTORIA trial . Looking at the HR and CI I am not that impressed . Also how are we going to apply this now with the DAPA-HF data Thoughts ?

May 17, 2020 · 4 likes · 1,943 followers View post →
Kaz Ueno
@kirin73934794 · X

Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction | NEJM って事はアデンパスも心不全に効果あるのかな? #NEJM https://t.co/IHYM5Uaktg

May 15, 2020 · 263 followers View post →
Alessio Gerussi
@AlessioGerussi · X

RT @jaumebosch9: An example for debating what degree of risk reduction could be considered clinically significant. Here is a 3.5% absolute…

May 15, 2020 · 2 shares · 418 followers View post →
Juan Turnes
@jturnesv · X

RT @jaumebosch9: An example for debating what degree of risk reduction could be considered clinically significant. Here is a 3.5% absolute…

May 15, 2020 · 2 shares · 6,189 followers View post →
jaumebosch
@jaumebosch9 · X

An example for debating what degree of risk reduction could be considered clinically significant. Here is a 3.5% absolute risk reduction (from 38.5 to 35%). And if it was NASH? Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction | NEJM https://t.co/TelsezpV6L

May 15, 2020 · 25 likes · 2 shares · 2,834 followers View post →
LLZ Consulting
@llzconsulting · X

Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction | NEJM https://t.co/53xPhods6C

May 15, 2020 · 270 followers View post →
john morley
@drjohnmorley · X

Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction | NEJM https://t.co/s5Lq6zSfZj

May 14, 2020 · 8,322 followers View post →
Sergey
@Sergey59869138 · X

Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction | NEJM https://t.co/ckpbqRSXPb

May 13, 2020 · 17 followers View post →
Martha Montaño
@MarthaM42370033 · X

Topic Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction

Apr 15, 2020 · 1 like · 3 followers View post →
官澤洋平 YK Hospitalist
@Yohei_Kanzawa · X

HFrEFは次々とエビデンスが集積されますよね。可溶性グアニル酸シクラーゼ刺激薬であるvericiguatがプラセボと比較して心血管死/心不全入院を減少。 #vericiguat #心不全 Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction | NEJM https://t.co/SRSWzRKcqR

Apr 11, 2020 · 1 like · 3,211 followers View post →
Sean Ninan
@sean9n · X

A new drug for heart failure! A guanylate cyclase stimulator - thought that was an ingredient in Red Bull. Bit busy right now. See you in 6 months. BW Sean https://t.co/0sMfYOnYDr

Apr 3, 2020 · 3 likes · 4,336 followers View post →
Med Peds Hospitalist
@medpedshosp · X

Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction | NEJM #meded #foamed ⁦@cardionerds⁩ #heartfailure https://t.co/gIfZqJUzYo

Apr 1, 2020 · 2 likes · 14,232 followers View post →
Jorge Salazar M
@SalazarMJA · X

Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction | NEJM https://t.co/wHNj7DxZFt

Apr 1, 2020 · 3 likes · 393 followers View post →
Igor Morr
@igormorr · X

RT @ernestocardio: Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction | NEJM https://t.co/ARGGoY5WX0 @mencardio @torre…

Mar 31, 2020 · 5 shares · 3,941 followers View post →
Fernando Rodriguez
@recetario1 · X

RT @ernestocardio: Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction | NEJM https://t.co/ARGGoY5WX0 @mencardio @torre…

Mar 31, 2020 · 5 shares · 1,589 followers View post →
MHC
@mtnhealthcare · X

Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction. https://t.co/nIhbWxkc9c

Mar 31, 2020 · 724 followers View post →
Ankit Patel
@ankitbpatel7 · X

Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction | NEJM. Will this work similar to ARNI therapy as ANP is thought to work through cGMP. Will be interesting to compare. Also to look at renal outcomes! https://t.co/Ex6d2AXNkb

Mar 30, 2020 · 1 like · 1,237 followers View post →
Thuo
@ThuoPap · X

Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction. https://t.co/5r1x9MnTWR

Mar 30, 2020 · 1,470 followers View post →
Hanna Gaggin
@HannaGaggin · X

RT @gcfmd: Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction | NEJM https://t.co/umwPqPbOmb

Mar 30, 2020 · 14 shares · 1,613 followers View post →
renalRCTs
@renalRCTs · X

Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction. https://t.co/szcOi0HUIZ

Mar 30, 2020 · 39 followers View post →
Cardio-Targets
@CardioTargets · X

Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction. https://t.co/XQSKKwcNYP

Mar 30, 2020 · 153 followers View post →
Emilia Martinez
@emartinezgmg · X

RT @ernestocardio: Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction | NEJM https://t.co/ARGGoY5WX0 @mencardio @torre…

Mar 29, 2020 · 5 shares · 1,010 followers View post →
Adams CardioMD
@AdamsCardioMD · X

Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction | NEJM https://t.co/Dwn3quMD6D

Mar 29, 2020 · 607 followers View post →
Kamile Cerlinskaite-Bajore
@cerlinskaite · X

RT @gcfmd: Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction | NEJM https://t.co/umwPqPbOmb

Mar 29, 2020 · 14 shares · 64 followers View post →
gabrielle wassell
@gabriellewasse1 · X

RT @JBauersachsMD: Significant reduction of CV death and #HF hospitalization by novel soluble guanylate Cyclase Stimulator: Vericiguat in P…

Mar 29, 2020 · 3 shares · 192 followers View post →
Paco Cano
@PacoCan51299504 · X

RT @Manugrillo2: Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction | NEJM https://t.co/nQuYRuWfPr

Mar 29, 2020 · 2 shares · 42 followers View post →
@SVC_FILIALANZOATEGUI
@cardioprevanz · X

RT @ernestocardio: Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction | NEJM https://t.co/ARGGoY5WX0 @mencardio @torre…

Mar 29, 2020 · 5 shares · 827 followers View post →
MaryFllr.base.eth
@MaryFllr1234 · X

Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction – https://t.co/LR7Z1WJWXX https://t.co/rPipJAUwdc

Mar 29, 2020 · 85 followers View post →
Ekaterini Lambrinou
@EkateriniL · X

RT @JBauersachsMD: Significant reduction of CV death and #HF hospitalization by novel soluble guanylate Cyclase Stimulator: Vericiguat in P…

Mar 29, 2020 · 3 shares · 3,386 followers View post →
Mahazarin Ginwalla
@MahazarinG · X

RT @gcfmd: Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction | NEJM https://t.co/umwPqPbOmb

Mar 29, 2020 · 14 shares · 816 followers View post →
de la Treille
@MarronnierFou · X

Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction | NEJM https://t.co/PIOaUyat1J #acc2020

Mar 29, 2020 · 253 followers View post →
Alex Kharlamov MD FESC FACC FEACVI
@drskharlamov · X

RT @gcfmd: Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction | NEJM https://t.co/umwPqPbOmb

Mar 28, 2020 · 14 shares · 1,679 followers View post →
Eric Weinhandl
@eric_weinhandl · X

Interesting trial of an sGC stimulator in chronic HF with EF <45%. Modest reduction in HF hospitalization rate. Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction | NEJM https://t.co/Pr8lJ6EwIH

Mar 28, 2020 · 2 likes · 2,733 followers View post →
Leonardo Hurtado
@LeoVonKardio · X

Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction | NEJM https://t.co/BwTClYKaZ2

Mar 28, 2020 · 357 followers View post →
mirecly2013
@mirecly2013 · X

RT @ernestocardio: Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction | NEJM https://t.co/ARGGoY5WX0 @mencardio @torre…

Mar 28, 2020 · 5 shares · 669 followers View post →
Ernesto Rodríguez H
@ernestocardio · X

Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction | NEJM https://t.co/ARGGoY5WX0 @mencardio @torresviera @igormorr @jstragazue @drjarayg @recetario1 @apoleo @Lguevaramath @DrPontecarlosi @emartinezgmg @mirecly2013 @jacardio @lugocastle @jpcostabel @ramicule

Mar 28, 2020 · 4 likes · 5 shares · 2,215 followers View post →
Henry Han
@HanCardiomd · X

#VICTORIA trial full paper in @NEJM

Mar 28, 2020 · 4 likes · 16,106 followers View post →
Michael Yin
@MikeYin19 · X

RT @gcfmd: Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction | NEJM https://t.co/umwPqPbOmb

Mar 28, 2020 · 14 shares · 154 followers View post →
Zeeshan Khan
@ZeeshanAKhanMD · X

Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction | NEJM https://t.co/GFfUGTGxB6

Mar 28, 2020 · 353 followers View post →
Emma Jean
@emma_leivers · X

Interesting results, but only 60% on triple therapy? Be good learn more as to why... Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction | NEJM #heartfailure https://t.co/N6FihqaRKv

Mar 28, 2020 · 4 likes · 235 followers View post →
Adem Aksoy
@Adem_AksoyMD · X

RT @JBauersachsMD: Significant reduction of CV death and #HF hospitalization by novel soluble guanylate Cyclase Stimulator: Vericiguat in P…

Mar 28, 2020 · 3 shares · 281 followers View post →
Abdelhamid Hamdy
@abdelhamed012 · X

Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction | NEJM https://t.co/i0azxi2ryK

Mar 28, 2020 · 3,302 followers View post →
Juan Górriz Magaña
@Juan_Gorriz · X

RT @doctorchecho: Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction | NEJM https://t.co/1lYyYwi19K

Mar 28, 2020 · 4 shares · 1,217 followers View post →
Jason Feinman, MD
@jjfein · X

RT @gcfmd: Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction | NEJM https://t.co/umwPqPbOmb

Mar 28, 2020 · 14 shares · 502 followers View post →
DrBecher
@DrBeat019 · X

Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction | NEJM https://t.co/8bhhclm8Pk

Mar 28, 2020 · 911 followers View post →
Michael Chetrit
@ChetritMichael · X

RT @gcfmd: Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction | NEJM https://t.co/umwPqPbOmb

Mar 28, 2020 · 14 shares · 1,095 followers View post →
Juan Carlos Elizalde:.
@JuanElizalde777 · X

RT @hect2701: Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction | NEJM HR 0.90; 95% CI, 0.83 to 0.98; P=0.02; is th…

Mar 28, 2020 · 6 shares · 2,360 followers View post →
Manu Morales Sánchez
@Manugrillo2 · X

Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction | NEJM https://t.co/nQuYRuWfPr

Mar 28, 2020 · 2 likes · 2 shares · 2,140 followers View post →
Gustavo Lopes
@GustavoLopesO · X

RT @ethanjweiss: This feels sort of

Mar 28, 2020 · 1 share · 154 followers View post →
BCaseMD
@BCase07 · X

RT @hect2701: Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction | NEJM HR 0.90; 95% CI, 0.83 to 0.98; P=0.02; is th…

Mar 28, 2020 · 6 shares · 795 followers View post →
vero
@vero33888154 · X

RT @doctorchecho: Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction | NEJM https://t.co/1lYyYwi19K

Mar 28, 2020 · 4 shares · 37 followers View post →
Dr. Hari Natarajan
@harinatarajan31 · X

Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction | NEJM https://t.co/SDV1RPD8pD

Mar 28, 2020 · 300 followers View post →
Dr Amar Puttanna
@AmarPut · X

Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction | NEJM https://t.co/jgcZ0nlSyT

Mar 28, 2020 · 4 likes · 3,619 followers View post →
Johann Bauersachs
@JBauersachsMD · X

Significant reduction of CV death and #HF hospitalization by novel soluble guanylate Cyclase Stimulator: Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction | NEJM https://t.co/K0trcZAkEy

Mar 28, 2020 · 10 likes · 3 shares · 2,733 followers View post →
Fernando Civeira
@FernandoCiveir1 · X

Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction | NEJM https://t.co/Ravn5fKL3z

Mar 28, 2020 · 343 followers View post →
Daniel Mark
@DanMarkMD · X

RT @gabrielsteg: Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction | NEJM https://t.co/GA1rF1aXOi

Mar 28, 2020 · 4 shares · 2,999 followers View post →
Felix Valencia
@FelixValencia10 · X

RT @hect2701: Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction | NEJM HR 0.90; 95% CI, 0.83 to 0.98; P=0.02; is th…

Mar 28, 2020 · 6 shares · 1,704 followers View post →
Dr. Luiz Silva
@DrLuizSilva1 · X

RT @gcfmd: Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction | NEJM https://t.co/umwPqPbOmb

Mar 28, 2020 · 14 shares · 390 followers View post →
Dr. Luiz Silva
@DrLuizSilva1 · X

RT @rblument1: Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction | NEJM https://t.co/1G6C4mVJW4

Mar 28, 2020 · 2 shares · 390 followers View post →
Tracy Temple
@tctcml · X

RT @gabrielsteg: Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction | NEJM https://t.co/GA1rF1aXOi

Mar 28, 2020 · 4 shares · 17 followers View post →
‘Sola Orimoloye, MD
@solaorimoloye · X

RT @rblument1: Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction | NEJM https://t.co/1G6C4mVJW4

Mar 28, 2020 · 2 shares · 368 followers View post →
Juan Manuel Hernandez
@JuanmaHernande · X

RT @hect2701: Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction | NEJM HR 0.90; 95% CI, 0.83 to 0.98; P=0.02; is th…

Mar 28, 2020 · 6 shares · 283 followers View post →
Marjan U. Mujib, MD, MPH, FACC
@mmujib · X

RT @gcfmd: Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction | NEJM https://t.co/umwPqPbOmb

Mar 28, 2020 · 14 shares · 55 followers View post →
Guillaume Bonnet
@guilbon · X

RT @gabrielsteg: Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction | NEJM https://t.co/GA1rF1aXOi

Mar 28, 2020 · 4 shares · 3,485 followers View post →
Ph.Gabriel Steg
@gabrielsteg · X

Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction | NEJM https://t.co/GA1rF1aXOi

Mar 28, 2020 · 9 likes · 4 shares · 2,955 followers View post →
Cindy Westerhout, PhD
@CindyWesterhout · X

RT @gcfmd: Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction | NEJM https://t.co/umwPqPbOmb

Mar 28, 2020 · 14 shares · 319 followers View post →
Roger Blumenthal
@rblument1 · X

Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction | NEJM https://t.co/1G6C4mVJW4

Mar 28, 2020 · 4 likes · 2 shares · 8,835 followers View post →
M. Pilar López
@MPilarLpez1 · X

RT @doctorchecho: Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction | NEJM https://t.co/1lYyYwi19K

Mar 28, 2020 · 4 shares · 1,377 followers View post →
Gonzalo L Alonso Salinas
@Gontxi7 · X

RT @doctorchecho: Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction | NEJM https://t.co/1lYyYwi19K

Mar 28, 2020 · 4 shares · 1,610 followers View post →
Alberto Esteban
@doctorchecho · X

Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction | NEJM https://t.co/1lYyYwi19K

Mar 28, 2020 · 6 likes · 4 shares · 6,000 followers View post →
Ethan J. Weiss
@ethanjweiss · X

This feels sort of

Mar 28, 2020 · 15 likes · 1 share · 30,102 followers View post →
George Wohlford
@GWohlfordPharmD · X

RT @gcfmd: Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction | NEJM https://t.co/umwPqPbOmb

Mar 28, 2020 · 14 shares · 454 followers View post →
nekonekoz
@nekonekoz · X

RT @hect2701: Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction | NEJM HR 0.90; 95% CI, 0.83 to 0.98; P=0.02; is th…

Mar 28, 2020 · 6 shares · 806 followers View post →
Dr Roxana Mehran
@Drroxmehran · X

RT @gcfmd: Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction | NEJM https://t.co/umwPqPbOmb

Mar 28, 2020 · 14 shares · 24,169 followers View post →
Boback Ziaeian
@boback · X

RT @gcfmd: Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction | NEJM https://t.co/umwPqPbOmb

Mar 28, 2020 · 14 shares · 3,360 followers View post →
Dr Sam Raza, MD FACC FACP FASE
@SamRRazaMD · X

RT @hect2701: Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction | NEJM HR 0.90; 95% CI, 0.83 to 0.98; P=0.02; is th…

Mar 28, 2020 · 6 shares · 11,430 followers View post →
Prof. Hector M. Garcia-Garcia
@hect2701 · X

Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction | NEJM HR 0.90; 95% CI, 0.83 to 0.98; P=0.02; is this 10% reduction enough to add it to the HF portafolio? #ACC2020 #ACC20 https://t.co/yPNK1JAuVQ

Mar 28, 2020 · 14 likes · 6 shares · 4,518 followers View post →
Gregg Fonarow MD
@gcfmd · X

Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction | NEJM https://t.co/umwPqPbOmb

Mar 28, 2020 · 39 likes · 14 shares · 11,823 followers View post →
William Baker
@wbaker0621 · X

Full paper now available on NEJM. Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction | NEJM https://t.co/8oSztRfSZj

Mar 28, 2020 · 3 likes · 1,175 followers View post →